Jiro Ikeda

534 citations
14 papers · 404 indexed · h-index 11
Topics
Cancer, Hypoxia, and Metabolism (4 papers)Vagus Nerve Stimulation Research (3 papers)Eicosanoids and Hypertension Pharmacology (3 papers)
Partner nations
JapanSwedenCanada

In The Last Decade

Jiro Ikeda

14 papers receiving 398 citations

Peers

Jiro Ikeda
Comparison fields: 5 of 68
  • Molecular Biology 169
  • Cancer Research 142
  • Immunology 85
  • Physiology 75
  • Cardiology and Cardiovascular Medicine 62
Replace Elke Marsch with:
Elke Marsch Netherlands
Weili Xue China
Shujian Wei China
Tongju Guan United States
Shengkai Zuo China
Guomin Xie China
Melroy Miranda Switzerland
Ainara G. Cabodevilla United States
Kim Bujold Canada
Weihua Wu China
Jiro Ikeda relative to Elke Marsch Netherlands Elke Marsch's profile →
Citations per field
00.5×1.5×2.2×
Elke Marsch · 1×
Citations per year

Countries citing papers authored by Jiro Ikeda

Since Specialization
Citations

This map shows the geographic impact of Jiro Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Ikeda more than expected).

Fields of papers citing papers by Jiro Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Ikeda. The network helps show where Jiro Ikeda may publish in the future.

Co-authorship network of co-authors of Jiro Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Ikeda. A scholar is included among the top collaborators of Jiro Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Ikeda. Jiro Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 23
2 31
3 8
4 45
5 35
6 60
7 30
8 26
9
Peroxisome Proliferator-activated Receptor γ Agonists Attenuate Palmitate-induced Endoplasmic Reticulum Stress through Up-regulation of Stearoyl-CoA Desaturase 1
4
10 17
11 10
12 35
13 21
14 59

About Jiro Ikeda

Jiro Ikeda is a scholar working on Biochemistry, Neurology and Cancer Research, having authored 14 papers that have together received 404 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Vagus Nerve Stimulation Research (3 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Cancer Research (142 citations), Biochemistry (37 citations) and Immunology (85 citations). Jiro Ikeda has collaborated with scholars based in Japan, Sweden and Canada. Frequent co-authors include Kenji Sunagawa, Toshihiro Ichiki, Hirohide Matsuura, Ryohei Miyazaki, Kotaro Takeda, Shiro Kitamoto, Tomotake Tokunou, Toru Hashimoto, Toru Hashimoto and Keita Inanaga. Their work appears in journals such as Circulation, PLoS ONE and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026